Tectonic Therapeutic (TECX) Other Accumulated Expenses (2017 - 2024)

Tectonic Therapeutic (TECX) has 8 years of Other Accumulated Expenses data on file, last reported at $330000.0 in Q1 2024.

• Other Accumulated Expenses for Q1 2024 came in at $330000.0, up 62.56% year-over-year; the trailing twelve-month figure through Mar 2024 was $330000.0 (up 62.56% YoY), and the FY2023 annual result was $383000.0, up 81.52% from the prior year.
• Other Accumulated Expenses eased to $330000.0 in Q1 2024 per TECX's latest filing, from $383000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $1.2 million in Q3 2021 and troughed at $1000.0 in Q3 2023.
• A 5-year average of $343764.7 and a median of $211000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2021 and 2023: Other Accumulated Expenses soared 519.9% in 2021, then sank 99.76% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $348000.0 in 2020, then tumbled by 48.85% to $178000.0 in 2021, then grew by 18.54% to $211000.0 in 2022, then surged by 81.52% to $383000.0 in 2023, then declined by 13.84% to $330000.0 in 2024.
• Business Quant data shows TECX's Other Accumulated Expenses at $330000.0 in Q1 2024, $383000.0 in Q4 2023, and $1000.0 in Q3 2023.